Targeting paraoxonase-1 in atherosclerosis

Area of Science:

• Biochemistry
• Cardiovascular Science
• Molecular Biology

Background:

• Paraoxonase-1 (PON1) is a calcium-dependent enzyme associated with high-density lipoprotein (HDL).
• PON1 exhibits lactonase activity and inhibits low-density lipoprotein (LDL) oxidation.
• Oxidized LDL is implicated in the pathogenesis of atherosclerosis, suggesting PON1's atheroprotective role.

Purpose of the Study:

• To review the existing literature on Paraoxonase-1 (PON1) in the context of atherosclerosis.
• To evaluate the evidence supporting and refuting PON1's atheroprotective capacity.
• To explore potential mechanisms underlying PON1's atheroprotection and its regulation in humans.

Main Methods:

• Literature search conducted using PubMed.
• Review and synthesis of relevant scientific articles on PON1 and atherosclerosis.
• Discussion of experimental and clinical findings related to PON1 function and regulation.

Main Results:

• PON1 demonstrates the ability to retard or inhibit LDL oxidation.
• Evidence suggests a potential atheroprotective role for PON1 due to its antioxidant properties.
• Current understanding of PON1 regulation in humans is discussed.

Conclusions:

• Existing data indicate that PON1 possesses atheroprotective properties.
• Further clinical and basic research is required to establish a causal link between PON1 and atherosclerosis.
• Elucidation of PON1's precise atheroprotective mechanisms and in vivo regulation in humans is necessary.